Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.01704-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Stephanie S May und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Telehealth Service, Intermountain Health, Murray, Utah, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, beta-Lactams, Anti-Bacterial Agents, Bacteremia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among 452 adult patients with Gram-negative bacteremia from a urinary tract infection source who received oral step-down therapy with highly bioavailable oral beta-lactam, we observed no difference in 60-day recurrence in patients treated with higher consensus-recommended dosing compared to lower, standard dosing (odds ratio = 0.76 [95% confidence interval = 0.43–1.32]), although the directionality of the effect was favorable. The study was limited by inadequate sample size and confounding. Randomized or large observational comparative effectiveness studies are needed. IMPORTANCE Definitive treatment of Gram-negative bacteremia with oral antibiotic agents is not one size fits all. Use of oral fluoroquinolones and sulfamethoxazole/trimethoprim is evidence-based but carries risk for adverse events. Data supporting the use of oral beta-lactams are mixed, likely in part due to variable agent selection and dosing. This analysis shows that higher, consensus-recommended dosing of highly bioavailable beta-lactam antibiotics was not significantly different from patients treated with lower dosing on 60-day recurrence. Our study was limited by the number of patients with discrete MICs and overinfluence of complicated urinary tract infection on outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Telehealth Service, Intermountain Health, Murray, Utah, USA.
- Department of Pharmacy, Intermountain Medical Center, Murray, Utah, USA.
- Statistical Data Center, Intermountain Health, Murray, Utah, USA.
- Department of Pharmacy, Primary Children's Hospital, Salt Lake City, Utah, USA.
- Division of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
- King Abdul Aziz Specialist Hospital, Taif, Makkah, Saudi Arabia.
ORCID-Profile: Stephanie S May, John J Veillette, Sameer Alzaidi, Brandon J Webb
Zitieren
APA
May, S. S., Veillette, J. J., Butler, A. M., Olson, J., Alzaidi, S., & Webb, B. J. (2026). Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01704-25
Vancouver
May SS, Veillette JJ, Butler AM, Olson J, Alzaidi S, Webb BJ. Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01704-25
BibTeX
@article{May2026,
author = {May, Stephanie S and Veillette, John J and Butler, Allison M and Olson, Jared and Alzaidi, Sameer and Webb, Brandon J},
title = {Effect of oral beta-lactam dosing on outcomes of bacteremic Gram-negative urinary tract infections: a real-world analysis},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01704-25}
}
EUVIMED